Home Antibody All anti-NAA40 antibodies
Also for NAA40 (NM_024771)
|NAT11 antibody was raised against a 15 amino acid peptide near the carboxy terminus of human NAT11.|
|WB, IHC, IF
||WB: 1 - 2 ug/ml, IHC: 5 ug/ml, IF: 20 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens N(alpha)-acetyltransferase 40, NatD catalytic subunit (NAA40), transcript variant 1|
|N-terminal acetylation is one of the most common protein modifications in eukaryotes, occurring on approximately 57% and 84% on yeast and human proteins respectively. There are several N-terminal acetylating enzyme complexes (NatA – NatE). Unlike the other complexes, NatD is composed of a single protein, NAT11, and has recently been described to acetylate the Serine N-termini of histones H2A and H4 in yeast. The role these modifications play is unknown; yeast that do not express NAT11 grow at normal rates and have no observable phenotypes. The role of the human homolog is likewise unknown.|
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of NAT11 in human thymus tissue lysate with NAT11 antibody at (A) 1 and (B) 2 ug/mL.
Immunohistochemistry of NAT11 in mouse thymus tissue with NAT11 antibody at 5 ug/mL.
Immunofluorescence of NAT11 in mouse thymus tissue with NAT11 antibody at 20 ug/mL.